UAS Laboratories LLC (Wausau, Wisconsin, USA) is pleased to announce the acquisition of Nebraska Cultures, Inc. a company which specializes in custom-manufactured probiotic solutions including the DDS®-1 strain of Lactobacillus acidophilus and the ProDURA® brand of spore-based probiotics.
Through this transaction, UAS Labs will accelerate their leadership in the fast-growing probiotic industry. UAS will offer their valued global partners a complete portfolio of stable products including exclusivity to one of the longest studied probiotic strains, Lactobacillus acidophilus DDS®-1. Furthermore, UAS will now provide spore-based probiotics utilizing the well-established ProDURA® brand. Maypro Industries, a distributor for Nebraska Cultures, will continue to support the ProDURA® line with their existing customer base.
Dr. Khem Shahani, founder of Nebraska Cultures, discovered and began research on the DDS®-1 strain of L. acidophilus in 1959. Throughout his career, Dr. Shahani published over 200 peer-reviewed scientific articles, many demonstrating the potential for DDS®-1 to improve health. Recognizing the strength of the strain, UAS Labs conducted multiple double-blind, gold standard clinical studies on DDS®-1. This acquisition brings together the history, science and success of DDS®-1 while allowing UAS Labs to continue the research and development of the unique strain.
Nebraska Cultures COO Michael Shahani comments, “We are honored to have served the nutraceutical industry for several decades, beginning in the 1950’s with my father’s pioneering research. We are thrilled to find in UAS a home where this work can contribute to tomorrow’s industry through the tremendous technical and production capabilities that this company provides.”
UAS Labs President and CEO, Kevin Mehring states, “We are extremely proud to have acquired a company that has shown strong values, impressive science and a dedication to the industry. This groundwork enables our passionate group of colleagues to further our company mission of providing leading and trusted probiotic-based solutions.”
Dr. Gregory Leyer, Chief Scientific Officer for UAS Labs continues, “We are honored to have the opportunity to write the next successful chapter for the DDS®-1 strain and are grateful for the work that the Shahani family has done to continue their fathers’ life work.”
Lakeview Equity Partners, LLC, the majority owner of UAS Labs, lead the acquisition effort which positions UAS to continue to grow as an industry leader in probiotics.
About UAS Laboratories
UAS Laboratories LLC has delivered the highest quality, science-backed probiotics to the marketplace since 1979. Strictly dedicated to probiotic manufacturing, UAS is committed to designing innovative and effective formulations that strive to enhance wellness and quality of life.
About Nebraska Cultures
Founded in 1981 as one of the first manufacturers to offer probiotic ingredients to the natural products industry, Nebraska Cultures helped set the stage for today’s widespread interest and growing consumer acceptance of probiotic supplementation for improved health. In addition to supplying probiotic raw materials, they maintain a focus on research and technology.
About Lakeview Equity Partners, LLC
Lakeview Equity Partners is a private equity investment fund that focuses on investments in Midwest-based, middle market companies. Lakeview Equity’s mission is to identify and invest in strong, well-managed companies to help them achieve continued growth and profitability and support ownership change, including ownership opportunities for managers and employees.